332 related articles for article (PubMed ID: 15148494)
1. An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting.
Bredeson C; Leger C; Couban S; Simpson D; Huebsch L; Walker I; Shore T; Howson-Jan K; Panzarella T; Messner H; Barnett M; Lipton J
Biol Blood Marrow Transplant; 2004 Jun; 10(6):405-14. PubMed ID: 15148494
[TBL] [Abstract][Full Text] [Related]
2. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
3. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
[TBL] [Abstract][Full Text] [Related]
4. Differences between graft product and donor side effects following bone marrow or stem cell donation.
Favre G; Beksaç M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szer J; Bradstock K; Buzyn A; Matcham J; Gratwohl A; Schmitz N;
Bone Marrow Transplant; 2003 Nov; 32(9):873-80. PubMed ID: 14561987
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in patients randomized to receive a bone marrow or a peripheral blood allograft.
De Souza CA; Durães MI; Vigorito AC; Penteado Aranha FJ; Oliveira GB; De Brito Eid KA; Zulli R; Cristina E; Miranda M; Botega NJ
Haematologica; 2002 Dec; 87(12):1281-5. PubMed ID: 12495902
[TBL] [Abstract][Full Text] [Related]
6. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.
Miller JP; Perry EH; Price TH; Bolan CD; Karanes C; Boyd TM; Chitphakdithai P; King RJ
Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):29-36. PubMed ID: 18721778
[TBL] [Abstract][Full Text] [Related]
7. Technical and safety aspects of blood and marrow transplantation using G-CSF mobilized family donors.
Kadar JG; Arseniev L; Schnitger K; Südmeier I; Zaki M; Battmer K; Jacobs R; Diedrich H; Poliwoda H; Stangel W; Link H
Transfus Sci; 1996 Dec; 17(4):611-8. PubMed ID: 10168561
[TBL] [Abstract][Full Text] [Related]
8. Mobilized blood cells vs bone marrow harvest: experience compared in 171 donors with particular reference to pain and fatigue.
Karlsson L; Quinlan D; Guo D; Brown C; Selinger S; Klassen J; Russell JA
Bone Marrow Transplant; 2004 Apr; 33(7):709-13. PubMed ID: 14755321
[TBL] [Abstract][Full Text] [Related]
9. Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional study.
Leitner GC; Baumgartner K; Kalhs P; Biener D; Greinix HT; Hoecker P; Worel N
Bone Marrow Transplant; 2009 Mar; 43(5):357-63. PubMed ID: 18936736
[TBL] [Abstract][Full Text] [Related]
10. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.
Schmitz N; Beksac M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szerm J; Bradstock K; Buzyn A; Schlegelberger B; Matcham J; Gratwohl A
Haematologica; 2005 May; 90(5):643-8. PubMed ID: 15921379
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective.
Couban S; Dranitsaris G; Andreou P; Price S; Tinker L; Foley R; Walker IR; Jamal S; Jamal N; Spaner D; Lipton J; Meharchand J; Messner HA
Bone Marrow Transplant; 1998 Dec; 22(12):1199-205. PubMed ID: 9894724
[TBL] [Abstract][Full Text] [Related]
12. Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.
Devine SM; Brown RA; Mathews V; Trinkaus K; Khoury H; Adkins D; Vij R; Sempek D; Graubert T; Tomasson M; Goodnough LT; DiPersio JF
Bone Marrow Transplant; 2005 Sep; 36(6):531-8. PubMed ID: 16025152
[TBL] [Abstract][Full Text] [Related]
13. Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
Sautois B; Baudoux E; Salmon JP; Michaux S; Schaaf-Lafontaine N; Pereira M; Paulus JM; Fillet G; Beguin Y
Haematologica; 2001 Nov; 86(11):1209-18. PubMed ID: 11694408
[TBL] [Abstract][Full Text] [Related]
14. Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC).
Bredeson C; Malcolm J; Davis M; Bence-Bruckler I; Kearns B; Huebsch L
Bone Marrow Transplant; 1997 Nov; 20(10):889-96. PubMed ID: 9404932
[TBL] [Abstract][Full Text] [Related]
15. Predonation health-related quality of life scores predict time to recovery in hematopoietic stem cell donors.
Billen A; Madrigal JA; Strydom A; Szydlo RM; Switzer GE; Shaw BE
Biol Blood Marrow Transplant; 2015 Feb; 21(2):350-6. PubMed ID: 25452034
[TBL] [Abstract][Full Text] [Related]
16. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
[TBL] [Abstract][Full Text] [Related]
17. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and graft characteristics in pediatric matched sibling donor transplants using granulocyte colony-stimulating factor-primed bone marrow and steady-state bone marrow.
Chiang KY; Haight A; Horan J; Olson E; Gartner A; Hartman D; Youssef S; Worthington-White D
Pediatr Transplant; 2007 May; 11(3):279-85. PubMed ID: 17430483
[TBL] [Abstract][Full Text] [Related]
19. [A comparative study of unrelated donor bone marrow transplantation and peripheral blood stem cell transplantation for their therapeutic effects on leukemia].
Fan ZP; Yang K; Liu QF; Sun J; Xu D; Zhang Y; Wei YQ; Ye CX; Jiang QL; Meng FY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1494-7, 1512. PubMed ID: 17062361
[TBL] [Abstract][Full Text] [Related]
20. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]